Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Cipla
Healthtrust
Citi
Argus Health

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 5,856,442

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,856,442
Title: Transcripts of the MHC class I HLA-G gene and their applications
Abstract:Transcripts of the major histocompatibility complex (MHC) Class I HLA-G gene which are present in foetal trophoblasts and/or in adult circulating mono-nuclear cells, as well as methods of using these. Either the said transcripts comprise, in succession in the 5\' to 3\' direction: a fragment encoding the signal peptide (exon 1), a fragment encoding the .alpha.1 domain (exon 2), a fragment encoding the .alpha.2 domain (exon 3), a fragment encoding the transmembrane TM domain (exon 5), a fragment encoding the cytoplasmic domain (exon 6) and the 3\' untranslated fragment (exon 8), which sequence is designated HLA-G4, or the said transcripts comprise intron 4.
Inventor(s): Carosella; Edgardo Delfino (Paris, FR), Moreau; Philippe (Viry-Chatillon, FR), Gluckman; Eliane (Paris, FR), Kirszenbaum; Marek (Orsay, FR)
Assignee: Commissariat a l\'Energie Atomique (Paris, FR)
Application Number:08/406,057
Patent Claims:see list of patent claims

Details for Patent 5,856,442

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Commissariat a l\'Energie Atomique (Paris, FR) 2016-01-05 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Commissariat a l\'Energie Atomique (Paris, FR) 2016-01-05 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Commissariat a l\'Energie Atomique (Paris, FR) 2016-01-05 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Daiichi Sankyo
Express Scripts
US Army
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.